Dr. Lonial is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd Ne
Atlanta, GA 30322Phone+1 404-778-1900
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1997 - 2000
- Baylor College of MedicineResidency, Internal Medicine, 1993 - 1997
- University of Louisville School of MedicineClass of 1993
Certifications & Licensure
- GA State Medical License 1997 - 2025
- TX State Medical License 1995 - 1999
Clinical Trials
- Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma Start of enrollment: 2008 Dec 01
- Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma Start of enrollment: 2008 Jun 01
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
- Join now to see all
Publications & Presentations
PubMed
- Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database.S Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer, Xiwu Lin, Sacheeta Bathija
Blood Cancer Journal. 2024-12-05 - A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies.Pinkal Desai, Sagar Lonial, Amanda Cashen, Manali Kamdar, Ian Flinn
Clinical Cancer Research. 2024-11-01 - Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity.Alberto Moreno, Kelly Manning, Maryam I Azeem, Ajay K Nooka, Madison Ellis
NPJ Vaccines. 2024-10-27
Journal Articles
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple MyelomaNikhil C Munshi, Larry D Anderson, Deepu Madduri, Sagar Lonial, Noopur Raje, Fabio Petrocca, Kristen Hege, The New England Journal of Medicine
- Article MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK ActivationGuojing Zhang, Fadlo R Khuri, Taofeek K Owonikoko, Dan Li, Conor E Steuer, Nabil F Saba, Dong M Shin, Sagar Lonial, ScienceDirect
- A Phase I/II Dose-Escalation Study Investigating All-Oral Ixazomib-Melphalan-Prednisone Induction Followed by Single-Agent Ixazomib Maintenance in Transplant-Ineligibl...Michael D Craig, Sagar Lonial, Haematologica
- Join now to see all
Abstracts/Posters
- Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM StudySagar Lonial, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...Sagar Lonial, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...Sagar Lonial, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Amyloidosis and Waldenstr_m Macroglobulinemia (Part 2 of a 2-Part Series)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Translational and Clinical Evidence of a Differentiated Profile for the Novel CELMoD, Iberdomide (CC-220)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- E3A06: Randomized phase III trial of lenalidomide versus observation alone in patients with asymptomatic high-risk smoldering multiple myeloma.2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Press Mentions
- Landmark Study Reveals New Insights into Multiple Myeloma ProgressionAugust 19th, 2024
- Georgia's First Immediate Care Center Specifically for Patients with Cancer Opens at WinshipApril 15th, 2022
- Gift Honoring David Lawson, MD, Endows Cancer Research Professorship at WinshipFebruary 4th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: